TYROBP and neoplasm: Additionally, even at doses exceeding the human therapeutic range, DAP12-based CAR-T cells did not induce significant adverse effects on body weight, temperature, or organ function with similar tumor eradication and 100% survival in a SKOV3 ovarian cancer xenograft model (104).